About the Company
Alzheimer's disease and cognitive decline affect far more than memory. They can change a person's independence, relationships, identity, and the lives of entire families. Alzheimer's Treatment Centers of America (ATCA) was created to challenge the idea that cognitive decline should simply be diagnosed, managed, and accepted.
ATCA is actually using Artificial Intelligence (AI) as part of its approach to patient care. Its patented AI platform works alongside personalized precision medicine to help identify and address more than 100+ potential root causes of cognitive decline, using patient-specific clinical data to help guide individualized treatment strategies.
The early results are compelling. In an observational study of ATCA's AI protocol, 80% of participants following the protocol showed no further decline in their mild cognitive impairment.
ATCA is bringing together clinical innovation, artificial intelligence, precision medicine, and multidisciplinary care to rethink how Alzheimer's disease, dementia, and related cognitive disorders are approached.
About the Role
ATCA is seeking accomplished healthcare executives, physicians, entrepreneurs, operators, investors, and business leaders to join its Advisory Board and help guide the company’s next phase of growth.
This role is for healthcare and technology leaders interested in how artificial intelligence can support clinical decision-making and more personalized approaches to complex patient care, including Alzheimer’s disease and cognitive decline.
ATCA’s AI platform is used alongside patient-specific clinical data and precision medicine. Advisory Board Members will help leadership think strategically about responsible adoption, clinical integration, and the role of AI in individualized care.
This strategic advisory role requires approximately 1 – 2 hours per month.
Key Responsibilities
Preferred Qualifications
Why Join ATCA?
This is an opportunity to help shape how ATCA applies artificial intelligence to individualized cognitive care.
Advisors will work with leadership at the intersection of healthcare, AI, patient-specific data, precision medicine, and clinical decision-making.
Qualified Advisory Board Members also have the opportunity to make a $50K+ angel investment alongside fellow advisors as the company continues its growth.